American Economic Journal:
Applied Economics
ISSN 1945-7782 (Print) | ISSN 1945-7790 (Online)
Modern Medicine and the Twentieth Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs
American Economic Journal: Applied Economics
vol. 2,
no. 2, April 2010
(pp. 118–46)
Abstract
This paper studies the contribution of sulfa drugs, a groundbreaking medical innovation in the 1930s, to declines in US mortality. For several infectious diseases, sulfa drugs represented the first effective treatment. Using time-series and difference-in-differences methods, we find that sulfa drugs led to a 24 to 36 percent decline in maternal mortality, 17 to 32 percent decline in pneumonia mortality, and 52 to 65 percent decline in scarlet fever mortality between 1937 and 1943. Altogether, sulfa drugs reduced mortality by 2 to 3 percent and increased life expectancy by 0.4 to 0.7 years. We also find that sulfa drugs benefited whites more than blacks. (JEL I12, L65, N32, N72)Citation
Jayachandran, Seema, Adriana Lleras-Muney, and Kimberly V. Smith. 2010. "Modern Medicine and the Twentieth Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs." American Economic Journal: Applied Economics, 2 (2): 118–46. DOI: 10.1257/app.2.2.118Additional Materials
JEL Classification
- I12 Health Production
- L65 Chemicals; Rubber; Drugs; Biotechnology
- N32 Economic History: Labor and Consumers, Demography, Education, Health, Welfare, Income, Wealth, and Religion: U.S.; Canada: 1913-
- N72 Economic History: Transport, Trade, Energy, Technology, and Other Services: U.S.; Canada: 1913-
There are no comments for this article.
Login to Comment